The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
Main Authors: | , , , , , , |
---|---|
其他作者: | |
格式: | Conference item |
語言: | English |
出版: |
Elsevier
2020
|
總結: |
---|
Main Authors: | , , , , , , |
---|---|
其他作者: | |
格式: | Conference item |
語言: | English |
出版: |
Elsevier
2020
|
總結: |
---|